These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8614809)
1. Heart attacks: gone with the century? Brown MS; Goldstein JL Science; 1996 May; 272(5262):629. PubMed ID: 8614809 [No Abstract] [Full Text] [Related]
2. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)]. Motz W MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487 [No Abstract] [Full Text] [Related]
3. Trials of lipid-lowering therapy in secondary prevention of coronary heart disease. Olsson AG; Pedersen T; Bergdahl B Curr Opin Lipidol; 1995 Dec; 6(6):369-73. PubMed ID: 8750250 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of statins in acute coronary syndromes. Foody JM; Nissen SE Am J Cardiol; 2001 Aug; 88(4A):31F-5F. PubMed ID: 11520485 [TBL] [Abstract][Full Text] [Related]
5. [Lipid metabolism and risk of myocardial infarction -- new findings and implications for treatment]. Cullen P; Schulte H; Assmann G Dtsch Med Wochenschr; 2005 Sep; 130(39):2220-5. PubMed ID: 16189760 [No Abstract] [Full Text] [Related]
6. Economic implications of lipid-lowering trials: current considerations in selecting a statin. Farmer JA Am J Cardiol; 1998 Sep; 82(6A):26M-31M. PubMed ID: 9766345 [TBL] [Abstract][Full Text] [Related]
7. The effect of intensive lipid lowering on coronary atheroma and clinical outcome. Houslay ES; Sarma J; Uren NG Heart; 2007 Feb; 93(2):149-51. PubMed ID: 17035507 [TBL] [Abstract][Full Text] [Related]
8. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence. Wong MC; Wang HH; Liu KS Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540 [No Abstract] [Full Text] [Related]
9. Statins in threatened stroke. Kaste M Stroke; 2003 Feb; 34(2):351-3. PubMed ID: 12574533 [No Abstract] [Full Text] [Related]
10. Trial clouds use of niacin with a statin. Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606 [No Abstract] [Full Text] [Related]
11. Statins for stroke: the second story? Plutzky J; Ridker PM Circulation; 2001 Jan; 103(3):348-50. PubMed ID: 11157683 [No Abstract] [Full Text] [Related]
12. LDL-Cholesterol is the King. Goumas GS Angiology; 2009; 60(3):387-8. PubMed ID: 19497926 [No Abstract] [Full Text] [Related]
13. [Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia]. Tvorogova MG; Susekov AV; Semenova OA; Kukharchuk VV; Titov VN Ter Arkh; 1998; 70(12):8-13. PubMed ID: 10067240 [TBL] [Abstract][Full Text] [Related]
14. Role of statin drugs in acute coronary syndromes. Rackley CE Curr Atheroscler Rep; 2002 May; 4(3):161-3. PubMed ID: 11931712 [No Abstract] [Full Text] [Related]
15. [Optimization of cholesterol reduction principles and clinical results of dual inhibition]. von Hodenberg E Internist (Berl); 2005 May; 46 Suppl 1():S18-23. PubMed ID: 15834540 [TBL] [Abstract][Full Text] [Related]
16. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Sniderman AD; Furberg CD; Keech A; Roeters van Lennep JE; Frohlich J; Jungner I; Walldius G Lancet; 2003 Mar; 361(9359):777-80. PubMed ID: 12620753 [No Abstract] [Full Text] [Related]
19. [Type 2 diabetic: risk same as after infarct. With LDL not only the quantity counts]. MMW Fortschr Med; 2004 Jun; 146(24):4. PubMed ID: 15366509 [No Abstract] [Full Text] [Related]